ARDS - Aridis Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARDS is currently covered by 2 analysts with an average price target of $9.66. This is a potential upside of $9.66 (0%) from yesterday's end of day stock price of $0.

Aridis Pharmaceuticals's activity chart (see below) currently has 2 price targets and 6 ratings on display. The stock rating distribution of ARDS is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ARDS is $1, Lowest price target is $1.

Most recent stock forecast was given by CARL BYRNES from NORTHLAND CAPITAL MARKETS on 23-Nov-2022. First documented stock forecast 10-Sep-2018.

Best performing analysts who are covering ARDS - Aridis Pharmaceuticals:

Louise Chen Carl Byrnes

Currently out of the existing stock ratings of ARDS, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$2

$1.92 (2400.00%)

$10

2 years 4 months 26 days ago
(23-Nov-2022)

0/3 (0%)

$1.1 (122.22%)

Buy

$25

$24.93 (35614.29%)

$25

5 years 2 months 23 days ago
(27-Jan-2020)

0/2 (0%)

$18.21 (268.19%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARDS (Aridis Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ARDS (Aridis Pharmaceuticals) with a proven track record?

LOUISE CHEN

Which analyst has the current lower performing score on ARDS (Aridis Pharmaceuticals) with a proven track record?

CARL BYRNES

Which analyst has the most public recommendations on ARDS (Aridis Pharmaceuticals)?

Louise Chen works at SCOTIABANK and has 1 price targets and 3 ratings on ARDS

Which analyst is the currently most bullish on ARDS (Aridis Pharmaceuticals)?

Louise Chen with highest potential upside - $24.93

Which analyst is the currently most reserved on ARDS (Aridis Pharmaceuticals)?

Carl Byrnes with lowest potential downside - $1.92

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?